Itemoids

You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

2026May › 28

BTIG

64 days ago

BTIG initiated research coverage with a buy rating, calling the biotech's experimental hair loss treatment a possible 'GLP-1 moment.'
South Korea's Kospi is at risk of a big drop as it's overly reliant on on Samsung and SK Hynix, according to BTIG

page 1 of 1